Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aimei Health Technology Co., Ltd ( (AFJK) ) has shared an announcement.
On January 5, 2026, Aimei Health Technology Co., Ltd. deposited $34,330.96 into its trust account to extend by one month, from January 6, 2026 to February 6, 2026, the deadline to complete its initial business combination, marking the fourteenth such extension under its governing documents. To fund this payment, the company issued an unsecured, non‑interest‑bearing promissory note in the same principal amount to its sponsor, Aimei Health Ltd, and to United Hydrogen Group Inc., which each contributed half of the funds and may elect to convert the note into private units of Aimei immediately prior to the closing of the planned business combination with United Hydrogen, aligning their financial interests with the successful completion of the deal and preserving the SPAC’s option to consummate the transaction for the benefit of its public shareholders.
More about Aimei Health Technology Co., Ltd
Aimei Health Technology Co., Ltd. is a special purpose acquisition company (SPAC) that has raised capital from public shareholders in a trust account with the aim of completing an initial business combination, currently focused on a proposed transaction with United Hydrogen Group Inc. in the Cayman Islands.
Average Trading Volume: 253,006
Technical Sentiment Signal: Strong Buy
Current Market Cap: $438.5M
See more data about AFJK stock on TipRanks’ Stock Analysis page.